Headline
The latest stories from AHA Today.
Cyber attackers are using Microsoft Exchange Server vulnerabilities to access Exchange server email accounts on an organization’s premises and install malware to facilitate long-term access to victim environments, the Microsoft Threat Intelligence Center announced.
The Senate Finance Committee voted 14-14 along party lines on President Biden’s nomination of Xavier Becerra to be the next Secretary of Health and Human Services.
In this AHA Physician Alliance podcast, Amy Ahasic, M.D., section chief for pulmonary and critical care medicine at Norwalk Hospital in Connecticut, shares how she applied skills learned from the Women’s Wellness through Equity and Leadership Project to the COVID-19 public health emergency.
With Ebola outbreaks in the Democratic Republic of the Congo and Guinea, the Centers for Disease Control and Prevention is reminding U.S. health care personnel about its Ebola infection control guidance.
The Food and Drug Administration has called on 25 firms to stop producing and issuing so-called “FDA registration certificates” to mask, respirator, face shield and other medical device makers and distributors that create the impression that FDA has approved or authorized their products.
The National Emergency Tele-Critical Care Network offers hospitals and health systems needing clinical support to care for seriously ill COVID-19 patients free telehealth access to critical care physicians, nurses and other clinical experts.
At a House Energy and Commerce Subcommittee on Health hearing , health care stakeholders urged Congress to consider how to ensure flexibilities remain for patients and health care providers in telehealth beyond the public health emergency.
The National Institutes of Health has halted a clinical trial evaluating the effectiveness of COVID-19 convalescent plasma in emergency department patients with mild-to-moderate COVID-19 symptoms and at least one risk factor for severe COVID-19 after an independent board concluded from the data…
AHA voiced support for the National Coronavirus Commission Act (S. 412), legislation that would create a national commission to examine lessons learned from the COVID-19 pandemic and how to improve public health readiness.
President Biden today announced a major partnership between Johnson & Johnson and Merck to manufacture the latest COVID-19 vaccine to be authorized for emergency use in the U.S.